Open Access<p>MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer</p>
Author(s) -
Tao Zuo,
Huandan Suo,
Lei Zhang,
Zining Jin,
Zhen Wang,
Danyu Wang,
Meng-Hsiu Wu,
Nanxi Peng,
Yujie Zhao,
Bin Chen
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s263998
Subject(s) - breast cancer , cancer research , immune system , cancer , proportional hazards model , survival analysis , oncology , biology , biomarker , immunohistochemistry , medicine , immunology , biochemistry
To study the expression of MRPL13 in breast cancer tissues using TCGA database, analyze the correlation between the expression and clinicopathological characteristics of patients, and explore the role of MRPL13 in the development of breast cancer (BC).